Phillip M. Renfro is Director at ENZON PHARMACEUTICALS INC (ENZN). They have made 5 open-market trades across 2 companies since 2008, most recently 2015-05-20.
CIK 0001313575
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $57K since 2008, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GSB | SELL | 2015-05-20 | 2015-05-22 | $3.27 | $93K | -6.0% | -2.0% | -2.0% |
| ENZN | BUY | 2008-11-14 | 2008-11-17 | $3.64 | $36K | -11.7% | -7.1% | -7.1% |
| ENZN | SELL | 2008-05-12 | 2008-05-13 | $9.49 | $142K | -11.7% | -7.1% | -7.1% |
| ENZN | SELL | 2008-05-09 | 2008-05-12 | $9.46 | $52K | -11.7% | -7.1% | -7.1% |
| GSB | BUY | 2008-04-04 | 2008-04-07 | $2.07 | $21K | -6.0% | -2.0% | -2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.